Fig. 7
From: Downregulation of TUSC3 promotes EMT and hepatocellular carcinoma progression through LIPC/AKT axis
TUSC3-LIPC inhibits EMT in hepatocellular carcinoma via Akt signaling pathway. A Overexpression of TUSC3 alters cell phenotype; Western blot analysis the expression of EMT signaling pathway (B, C) and AKT signaling pathway (D, E) in shTUSC3-transfected MHCC97H and TUSC3-transfacted Bel-7404 cell as well as siLIPC-transfected MHCC97H and LIPC-transfected Bel-7404 cell; F, G Western blot analysis the expression of EMT signaling pathway and PI3K–AKT signaling pathway in shTUSC3-transfected or siLIPC-transfected MHCC97H cell treated with MK2206